TickerFactsScreenerDevelopers

UroGen Pharma Ltd. (URGN) — Operating Income

Annual figures by fiscal year, from SEC filings.

2015: -$12.41M2016: $798.0K2017: -$19.95M2018: -$77.18M2019: -$109.48M2020: -$126.74M2021: -$92.29M2022: -$79.04M2023: -$65.54M2024: -$96.78M2025: -$124.86M-$124.86M
2015Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$124.86M-29.0%
2024-$96.78M-47.7%
2023-$65.54M+17.1%
2022-$79.04M+14.4%
2021-$92.29M+27.2%
2020-$126.74M-15.8%
2019-$109.48M-41.8%
2018-$77.18M-286.9%
2017-$19.95M-2600.0%
2016$798.0K+106.4%
2015-$12.41M—